IRS1 and metabolic dysfunction-associated steatohepatitis: A reduced expression of the insulin receptor and insulin receptor substrate-1/2 (IRS-1/2) is associated with impairment of insulin-signaling and expression of Irs-1/2 in NASH subjects is markedly lower than that seen in healthy individuals [17].